Jeffrey Song

PGY-1 @OSU_Urology | @BCMHouston ‘25, @VanderbiltU ‘21

[Jeffrey Song @JeffreySongMD]

Ecstatic to be joining OSU Urology! Can’t wait to meet my co-residents!

[Ohio State Wexner Medical Center Urology Dept. @OSU_Urology]

We are thrilled to extend a big #Buckeye welcome to our incoming PGY1 class:
🌰@VivianHuaMed
🌰@hannahhingtgen
🌰@AAppletonMD2Be
🌰@JeffreySong_

#UroMatch #UroRes #Match2025 #AUAMatch #UroMatch2025 #StreamTeam

@OSUWexMed @OSUCCC_James @NCHUrology @ctleeuro @nntadros

[Ohio State Wexner Medical Center Urology Dept. @OSU_Urology]

From the football field to the operating room, excellence is our tradition. Proud to train tomorrow’s urology leaders—see you at #UroMatch interviews!

We are excited to offer both in-person and virtual interviews again this year!

#AUAMatch #Match2026 #UroRes @NCHUrology

[Ohio State Wexner Medical Center Urology Dept. @OSU_Urology]

Our interns — Ashley Appleton, @hannahhingtgen, @JeffreySongMD, @VivianHuaMed — along with Program Director @nntadros and faculty member @MSLee_MD attended the @AmerUrological Fundamental in Urology course! Thank you to @CleClinicUro for hosting! @OSUWexMed @OhioStateMed

[Ohio State Wexner Medical Center Urology Dept. @OSU_Urology]

Another great #simulation lab! Thank you to our faculty who provided expertise and to @bostonsci and their mobile lab for stopping by! Trainees practiced artificial urinary sphincters, penile implants, and urethral slings! #MedEd #UroRes #UroMatch @bsc_urology @springerej

[Jeffrey Song @JeffreySongMD]

@d_sevilmis So happy for you friend 🤩

[Mohit Khera @DrMohitKhera]

Great news! The FDA updated testosterone product labels today. The TRAVERSE trial found no increased CV risk, so the boxed warning is planned to be removed! However, a blood pressure warning has been added after ABPM studies. Use remains limited to men with medical conditions causing low T.

[Mohit Khera @DrMohitKhera]

BCM Andrology Research Scholar (BARS) 2025-2026: paid, 1-year position with amazing resources and mentorship!

Great opportunity for anyone considering a research year.

Link to apply: https://t.co/6wG2LhJnCt

[Jeffrey Song @JeffreySongMD]

Matched to the best specialty 🤩 Forever grateful #UroMatch #UroSoMe #Match2025

[Mohit Khera @DrMohitKhera]

BCM Andrology Research Scholar (BARS) 2025-2026: paid, 1-year position with amazing resources and mentorship!

Great opportunity for anyone considering a research year.

Link to apply: https://t.co/6wG2LhJVs1

[Michigan Urology @UMichUrology]

Calling all Medical Students! Learn more and apply by Jan 20, 2025 https://t.co/Ua4wkw8sZK

[Urology Practice @UrologyPractice]

Hear from the author! Thank you @JeffreySong_ for giving insights on the article, "Long-Term Satisfaction With Collagenase Clostridium Histolyticum for Peyronie's Disease: Clinical Predictors and Side Effect Profile."

Click the link to read it now! ➡️ https://t.co/u2yh0sAcoi

[Jeffrey Song @JeffreySongMD]

Grateful for the opportunity to present some of the findings from my UCF Medical Student Research Fellowship project at #SMSNA24!

[Gal Saffati @GalSaffatiMD]

Proud of the BCM team for presenting 37 abstracts at SMSNA this year! ⭐️

@DrMohitKhera @DrLipshultzTips @StocksBlair @bcm_urology @SMSNA_ORG

[Daniela Orozco Rendon🇨🇴 @danielaoro1471]

ERAS application officially submitted! Looking forward to this nerve wrecking but exciting journey. Time to work on some art projects to keep my mind off the nerves! Incredibly thankful for all my mentors along the way #Match2025 #urology #HUSNA @HispanicUroNA

[Jeffrey Song @JeffreySongMD]

Officially submitted ERAS! I’m Jeffrey, a @bcmhouston MS4 applying #urology in #Match2025!

I’m passionate about sexual medicine, recon, and medical education. You can find me bouldering, watering my 30 indoor plants, and playing with my maltipoo, Honey.

#UroSoMe #UroMatch

[Jeffrey Song @JeffreySongMD]

Proud of this labor of love and amazing team: @GalSaffatiMD @MichelleDai88 @TaherMNaeem @DrLipshultzTips @DrMohitKhera. Check out our study characterizing long-term satisfaction with CCH injections for Peyronie’s Disease: https://t.co/Giv6KGKrCd

[Jeffrey Song @JeffreySongMD]

Thrilled to see our study published in European Urology! Check out our systematic review and mapping of advanced prostate cancer therapy cardiotoxicity here: https://t.co/s4CLWfWu51

[Andrew Afyouni @AndysheaAfyouni]

Thankful to all the residents and faculty at @VUMCurology for a memorable and incredible subI experience. Honored and humbled to have had this opportunity and to do so along some of the best colleagues and now friends @devin_boehm @JeffreySong_ Karissa and Andrew.

[Mohit Khera @DrMohitKhera]

Finally, the long-awaited TRAVERSE Prostate Safety Study has just been released.

During 14,304 person-years of follow-up on 5204 men (aged 45-80 years) with hypogonadism in this randomized clinical trial, incidences of high-grade or any prostate cancer, acute urinary retention, invasive surgical procedures, and new pharmacologic BPH treatments were low and did not differ significantly between the testosterone and placebo-treated groups.

Maybe we can now stop debating about testosterone and prostate safety! @JAMANetworkOpen

https://t.co/YZOzndtVzV

[Jeffrey Song @JeffreySongMD]

Thank you @UrologyTimes for highlighting our work! I had a great time presenting at #SMSNA23!
@MichelleDai88 @TaherMNaeem @GalSaffatiMD @DrMohitKhera

[Urology Times @UrologyTimes]

Study identifies clinical predictors of patient satisfaction with CCH for Peyronie’s disease. #SMSNA23 #urology #urologist @JeffreySong_ @bcm_urology

Read more: https://t.co/wnGRfMwkAF